A revolutionary medication , retatrutide, is sparking considerable excitement in the field of obesity treatment . This dual-action injectable therapy works by imitating the effects of two gut hormones, GLP-1 and GIP, which inherently regulate food intake and enhance feelings of fullness . Early clin